secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001437749-23-027048
Event type: other
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Atossa receives Nasdaq deficiency notice for bid price below $1 for 30 days
---------------------------------------------------------------------------

- Nasdaq letter dated September 26, 2023, citing non-compliance with Listing Rule 5550(a)(2) for minimum bid price.
- Company has until March 25, 2024 to regain compliance; no immediate effect on listing or trading.
- To regain compliance, closing bid price must be $1.00 or higher for at least 10 consecutive business days.
- Company plans to monitor bid price and consider available options to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000143774923027048/0001437749-23-027048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000143774923027048/atos20230925_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-027048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer